A phase Ib study of preoperative, locoregional IRX-2 cytokine immunotherapy to prime immune responses in patients with early stage breast cancer
2019 ◽
Vol 26
(7)
◽
pp. 1595-1605
◽
2015 ◽
Vol 26
(2)
◽
pp. S131
Keyword(s):
Keyword(s):